Monday, December 21, 2015

Stocosil Proceeds with NDA filing of ST-101 under 505(b)(2) Regulatory Pathway

Responses from End-of-Phase 2 FDA Meeting Provide Clarity on Next Steps

via Technology - United States - Latest News http://ift.tt/1JolsTG
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)